Feed IVVD
IV

Invivyd, Inc.

IVVD · NASDAQ

$0.83 -5.69% (-$0.05)
1M +12.09%
Market Cap $262.7M
P/E Ratio -
Div. Yield -
ROE 59.73%
Piotroski F-Score Weak
1/9
Valuation
70 /100
Cheap
P/B 1.45x
P/S 4.50x
PEG N/A
Growth
0 /100
Declining
Book val. growth 12.13%
Rev. growth N/A
FCF growth N/A
Profitability
20 /100
Weak
FCF margin 187.88%
Op. margin 192.81%
Gross margin 91.35%
Quality
3 /100
Poor
Asset turnover 0.27x
ROA 49.04%
ROIC 59.39%
Debt
100 /100
Low
Current ratio 5.87x
Debt/Equity 0.05x
Net debt/EBITDA N/A
Stability
62 /100
Moderate
EPS volatility 34.84%
Profitable years 0
Beta 0.71x

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o IVVD
Online

O podjetju

Invivyd, Inc. (IVD) is an American company specializing in the development and provision of innovative solutions in the field of digital healthcare. With a product portfolio that includes health technologies, telemedicine, and digital diagnostics, Invivyd, Inc. is a key player in the transformation of the healthcare sector. The company focuses on providing efficient and affordable digital tools for monitoring and improving healthcare. Invivyd, Inc. (IVD) also keeps a close eye on emerging trends in e-health and consistently invests in research and development. Shares of Invivyd, Inc. (IVD) could be suitable for investors looking to invest in digital healthcare with an emphasis on innovation and enhancing patient care.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

William E. Duke Jr.

Employees

122

Headquarters

New Haven

Prihajajoči dogodki

05 NOV.

Earnings

Upcoming earnings report

50d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.